We corroborated these results with analysis of TCGA PRAD, data which confirmed that the expression profiles of AKT1 and miR-143-3p displayed a significant negative correlation in these samples (Figure 2c). The gene discussed is AKT1; the disease is prostate adenocarcinoma.